Login / Signup

Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol.

Paulo Márcio PitrezSira NanthapisalAna Paula Beltran Moschione CastroChirag TeliAbhijith P G
Published in: BMJ open respiratory research (2023)
FP/SAL is a reliable treatment option in patients not achieving control with ICS monotherapy or a different ICS/LABA combination. Evidence shows that FP/SAL is well tolerated and has a similar safety profile to FP monotherapy. Thus, FP/SAL provides an effective option for the management of moderate-to-severe asthma in the paediatric population.
Keyphrases